Mabcure Inc

0.0045+0.0010+28.57%Vol 10.14K1Y Perf 80.00%
Dec 3rd, 2021 09:44
BID0.0000 ASK0.0000
Open0.0045 Previous Close0.0035
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
21.74 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha0.26 Standard Deviation0.93
Beta-1.14 

Today's Price Range

0.00450.0045

52W Range

0.00050.0189

5 Year PE Ratio Range

0.00000.0000

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-21.05%
1 Month
-34.78%
3 Months
350.00%
6 Months
-10.00%
1 Year
80.00%
3 Years
95.65%
5 Years
7.14%
10 Years
0.00%

TickerPriceChg.Chg.%
MBCI0.00450.001028.57
AAPL161.84-1.9200-1.17
GOOG2 850.41-25.1200-0.87
MSFT323.01-6.4800-1.97
XOM60.89-0.3900-0.64
WFC47.75-1.1600-2.37
JNJ159.382.29001.46
FB306.84-3.5500-1.14
GE92.77-2.4600-2.58
JPM158.29-2.9200-1.81
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume10.14K
Shares Outstanding0
Shares Float31.04M
Trades Count1
Dollar Volume46
Avg. Volume89.80K
Avg. Weekly Volume10.49K
Avg. Monthly Volume54.31K
Avg. Quarterly Volume73.20K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Mabcure Inc

MabCure Inc is engaged in the business of developing and commercializing its proprietary antibody technology for the early detection of cancer and for the creation of specific therapeutics against cancer.

CEO: Amnon Gonenne

Telephone: +1 845 591-3144

Address: 275 Palm Beach Drive, New York 10003, NY, USA

Number of employees: 3

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

54%46%

Bearish Bullish

60%40%

News